Tesamorelin vs Sermorelin: Choosing the Right Peptide for Your Research Choose Tesamorelin When: The primary research endpoint is visceral adipose tissue (VAT) reduction Rapid, measurable IGF-1 elevation is needed within a short protocol window Studying metabolic syndrome, abdominal obesity, or lipodystrophy models Extended protocol stability is required (tesamorelin resists enzymatic degradation better) Research budget supports a higher-cost compound for a shorter, intensive protocol Choose Sermorelin When: The focus is long-term endocrine system support and hormonal homeostasis Sleep architecture and recovery pathways are the primary study variables Anti-aging, collagen synthesis, or longevity markers are being investigated A physiological, pulsatile GH release pattern is required to preserve feedback loops Cost efficiency over a long-duration protocol is a consideration The comparison extends beyond just these two peptides
Researchers at Eli Lilly engineered it with strategic amino acid substitutions that allow it to activate both the GIP receptor and the GLP-1 receptor simultaneously
Adaptogens A final class of supplements worth mentioning are adaptogens
European Journal of Clinical Nutrition , 72(1), 105111
For example, if a provider administers an injection in the arm but documents the leg, the claim may be questioned
